Pulmonx (LUNG) Other Non Operating Income (2019 - 2025)
Pulmonx's (LUNG) quarterly Other Non Operating Income came in at $758000.0 in Q3 2025, up 477.11% year-on-year from $131343.1 in Q3 2024, and up 753.45% on a QoQ basis from -$116000.0 in Q2 2025.
Pulmonx (LUNG) Other Non Operating Income (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Other Non Operating Income data on file, last reported at $758000.0 in Q3 2025.
- On a quarterly basis, Other Non Operating Income rose 477.11% year-over-year to $758000.0 in Q3 2025; TTM through Sep 2025 was $886000.0, a 597.75% increase from a year earlier, with the FY2024 full-year figure at $256000.0, up 138.04% from the prior year.
- Other Non Operating Income for Q3 2025 stood at $758000.0, up from -$116000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for LUNG reached as high as $758000.0 in Q3 2025 and fell as low as -$432000.0 in Q3 2022.
- Historically, Other Non Operating Income has averaged -$32722.2 across 5 years, with a median of -$106000.0 in 2021.
- Across the five-year window, Other Non Operating Income tumbled 277.61% in 2023 and soared 477.11% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at -$383000.0 in 2021, then soared by 152.48% to $201000.0 in 2022, then tumbled by 277.61% to -$357000.0 in 2023, then jumped by 121.57% to $77000.0 in 2024, then surged by 884.42% to $758000.0 in 2025.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $758000.0 in Q3 2025, -$116000.0 in Q2 2025, and $167000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Pulmonx | 49.94 Mn | -19.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 758,000.00 |
| Jun 30, 2025 | -116,000.00 |
| Mar 31, 2025 | 167,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | -201,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Mar 31, 2024 | 415,000.00 |
| Dec 31, 2023 | -357,000.00 |
| Sep 30, 2023 | -262,000.00 |
| Jun 30, 2023 | -162,000.00 |
| Mar 31, 2023 | 108,000.00 |
| Dec 31, 2022 | 201,000.00 |
| Sep 30, 2022 | -432,000.00 |
| Jun 30, 2022 | -165,000.00 |
| Dec 31, 2021 | -383,000.00 |
| Sep 30, 2021 | -267,000.00 |
| Jun 30, 2021 | -96,000.00 |
| Mar 31, 2021 | 161,000.00 |
| Dec 31, 2020 | 230,000.00 |
| Sep 30, 2020 | 2.63 Mn |